Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
MYC regulates the antitumor immune response through CD47 and PD-L1
2016 Science
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Fumarate induces redox-dependent senescence by modifying glutathione metabolism
2015
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer
2019 StandoutNobel
Epigenetic influence of environmentally neurotoxic metals
2020
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer
2016 StandoutNobel
Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations
2007 StandoutNobel
Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs
2016 Standout
The growing family of hereditary renal cell carcinoma
2004
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
2016
Alterations of metabolic genes and metabolites in cancer
2012
Oncometabolites: linking altered metabolism with cancer
2013
Pancreatic cancer
2004 Standout
A Decrease of Regulatory T Cells Correlates With Overall Survival After Sunitinib-based Antiangiogenic Therapy in Metastatic Renal Cancer Patients
2010
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
2012 Standout
Hereditary Kidney Cancer Syndromes
2013
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
2015
Cushing's syndrome
2015 Standout
NRF2 and cancer: the good, the bad and the importance of context
2012
Hallmarks of aging: An expanding universe
2023 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Improving de novo protein binder design with deep learning
2023 StandoutNobel
Antibody-based proteomics: fast-tracking molecular diagnostics in oncology
2010
The Contributions of HIF-Target Genes to Tumor Growth in RCC
2013
A systematic review of predictive and prognostic biomarkers for VEGF-targeted therapy in renal cell carcinoma
2013
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Rab GTPases as coordinators of vesicle traffic
2009 Standout
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
2012
The emerging role of the Nrf2–Keap1 signaling pathway in cancer
2013
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Unsuspected task for an old team: Succinate, fumarate and other Krebs cycle acids in metabolic remodeling
2014
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Interaction of tumor cells and lymphatic vessels in cancer progression
2011
Mitochondrial reactive oxygen species and cancer
2014
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
The Proto-oncometabolite Fumarate Binds Glutathione to Amplify ROS-Dependent Signaling
2013
Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity
2014
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Spectrin Domain of Eukaryotic Initiation Factor 3a Is the Docking Site for Formation of the a:b:i:g Subcomplex
2013
Structure of mammalian eIF3 in the context of the 43S preinitiation complex
2015 StandoutNatureNobel
Renal-Cell Carcinoma
2005
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
2015
The genetic basis of kidney cancer: a metabolic disease
2010
The RASSF1A Tumor Suppressor Activates Bax via MOAP-1
2005
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma
2011
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Microenvironmental regulation of metastasis
2008 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
2011
Antiangiogenic therapy in oncology: current status and future directions
2016
Regulation of endocytosis via the oxygen-sensing pathway
2009
The Folliculin Tumor Suppressor Is a GAP for the RagC/D GTPases That Signal Amino Acid Levels to mTORC1
2013
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Metabolic dysregulation in monogenic disorders and cancer — finding method in madness
2015
Mitochondrial TCA cycle metabolites control physiology and disease
2020 Standout
Lymphangiogenesis and lymphatic metastasis in breast cancer
2009
MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
2011
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial
2012
History of myeloid-derived suppressor cells
2013
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Renal cell carcinoma
2017 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma
2010
Autophagy in the liver: functions in health and disease
2017
Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy
2013
Lymphatic Vessel Activation in Cancer
2008
Pancreatic cancer
2011 Standout
The RASSF proteins in cancer; from epigenetic silencing to functional characterization
2009
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment
2017
Molecular Biology and Pathology of Lymphangiogenesis
2008 Standout
Fundamentals of cancer metabolism
2016 Standout
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
2013
Recruitment of folliculin to lysosomes supports the amino acid–dependent activation of Rag GTPases
2013
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
2015
Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation
2018 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)
2008
Works of David Petillo being referenced
Preparing the “Soil”: The Primary Tumor Induces Vasculature Reorganization in the Sentinel Lymph Node before the Arrival of Metastatic Cancer Cells
2006
CUL3 and NRF2 Mutations Confer an NRF2 Activation Phenotype in a Sporadic Form of Papillary Renal Cell Carcinoma
2013
Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma
2010
Genome-wide scan identifies novel modifier loci of acromegalic phenotypes for isolated familial somatotropinoma
2009
An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma
2011
The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas
2003
Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma
2011
Somatic Pairing of Chromosome 19 in Renal Oncocytoma Is Associated with Deregulated ELGN2-Mediated Oxygen-Sensing Response
2008
Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia
2008
Gene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma
2010
Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's Disease
2012
Inactivation of BHD in sporadic renal tumors.
2003
2671
2006
MicroRNA profiling of human kidney cancer subtypes
2009
The E2F3-Oncomir-1 Axis Is Activated in Wilms' Tumor
2008
Combining differential expression, chromosomal and pathway analyses for the molecular characterization of renal cell carcinoma
2012